AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 97 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2023. The put-call ratio across all filers is 0.03 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $738,783 | +354.1% | 212,294 | +732.5% | 0.02% | +275.0% |
| Q1 2024 | $162,690 | -83.6% | 25,500 | -83.5% | 0.00% | -87.9% |
| Q4 2023 | $992,816 | +129.8% | 154,164 | +133.9% | 0.03% | +6.5% |
| Q3 2021 | $432,000 | +37.6% | 65,900 | +39.5% | 0.03% | +3.3% |
| Q2 2021 | $314,000 | +177.9% | 47,255 | +138.7% | 0.03% | +172.7% |
| Q1 2021 | $113,000 | – | 19,795 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $74,286,965 | 86.51% |
| TFG Asset Management GP Ltd | 8,000,000 | $27,840,000 | 6.94% |
| STEMPOINT CAPITAL LP | 2,662,732 | $9,266,307 | 2.72% |
| Exome Asset Management LLC | 839,472 | $2,921,362 | 2.54% |
| GREAT POINT PARTNERS LLC | 3,441,667 | $11,977,001 | 2.29% |
| Affinity Asset Advisors, LLC | 4,300,000 | $14,964,000 | 1.72% |
| Deep Track Capital, LP | 15,272,172 | $53,147,159 | 1.59% |
| Frazier Life Sciences Management, L.P. | 4,623,324 | $16,089,168 | 0.75% |
| HighVista Strategies LLC | 518,820 | $1,805,494 | 0.66% |
| Avoro Capital Advisors LLC | 12,345,678 | $42,962,959 | 0.57% |